{"id":619220,"title":"Regulatory roadmap for biologic (Schedule D) drugs in Canada - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-07","captureTimestamp":"2026-03-07T02:13:48.672000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/regulatory-roadmap-for-biologic-drugs.html","snippet":"Regulatory roadmap for biologic (Schedule D) drugs in Canada This regulatory roadmap gives comprehensive, general information about the regulation of biologic drugs for human use in Canada. All drugs that are marketed in Canada are subject to the Food and Drugs Act and…","rawSnapshotUrl":"/api/snapshots/raw/619220","browseUrl":"https://replay.healtharchive.ca/job-6/20260307021348/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/regulatory-roadmap-for-biologic-drugs.html#ha_snapshot=619220","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}